Research & Professional Achievements
My research focuses on genetic engineering for regenerative medicine and the study of signalling pathways involved in cellular differentiation.
“Nanobiotechnological injectible extracellular matrix (ECM) for cartilage regeneration, personalized therapy and identification of "individual" microbe metabolites involved in joint degeneration” (project code: T1EDK-04567, funded by the EU/National Action "Research-Create-Innovate").
Mantsou, A., Papachristou, E., Keramidas, P., Lamprou, P., Pavlidis, A., Papi, R.M., Dimitriou, K., Aggeli, A. & Choli-Papadopoulou T. (2023). A Novel Drastic Peptide Genetically Adapted to Biomimetic Scaffolds “Delivers” Osteogenic Signals to Human Mesenchymal Stem Cells. Nanomaterials, 13(7), 1236.
Mantsou, A.‡ , Papachristou, E.‡ , Keramidas, P., Lamprou, P., Pitou, M., Papi, R.M., Dimitriou, K., Aggeli, A. & Choli-Papadopoulou, T. (2023). Fabrication of a Smart Fibrous Biomaterial That Harbors an Active TGF-β1 Peptide: A Promising Approach for Cartilage Regeneration. Biomedicines, 11(7), 1890.
Mantsou, A., Pitou, M., Papachristou, E., Papi, R.M., Lamprou, P. & Choli-Papadopoulou, T. (2021). Effect of a Bone Morphogenetic Protein-2-derived peptide on the expression of tumor marker ZNF217 in osteoblasts and MCF-7 cells. Bone reports, 15, 101125.